The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 11, 2022

Filed:

Sep. 27, 2017
Applicant:

Glaxosmithkline Biologicals S.a., Rixensart, BE;

Inventors:

Wivine Burny, Rixensart, BE;

Cindy Castado, Rixensart, BE;

Sandra Giannini, Rixensart, BE;

Julien Thierry Massaux, Rixensart, BE;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/12 (2006.01); C12N 15/86 (2006.01); A61P 31/20 (2006.01); A61K 35/761 (2015.01); C07K 14/005 (2006.01); C12N 7/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C12N 15/86 (2013.01); A61K 35/761 (2013.01); A61K 39/12 (2013.01); A61P 31/20 (2018.01); C07K 14/005 (2013.01); C12N 7/00 (2013.01); A61K 2039/5256 (2013.01); C07K 2319/40 (2013.01); C12N 2710/10343 (2013.01); C12N 2710/20022 (2013.01); C12N 2710/20034 (2013.01);
Abstract

The present invention relates to nucleic acid constructs capable of encoding antigenic peptides or polypeptides derived from multiple Human Papilloma Virus (HPV) early proteins, and to immunogenic compositions comprising such nucleic acid constructs and a pharmaceutically acceptable carrier. Such nucleic acid constructs and immunogenic compositions are useful in the treatment of persistent HPV infection and low-grade HPV lesions, particularly infections and lesions of human anogenital epithelial tissue, such as cervical epithelia.


Find Patent Forward Citations

Loading…